EN
抗体药类似物
Research Grade Teclistamab
All
TD-HX959026_1.jpg
TD-HX959026_2.jpg
TD-HX959026_3.jpg
  • CatalogTD-HX959026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,BCMA,JNJ-64007957,JNJ-7957,Ab-957,CAS:2119595-80-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Teclistamab


Catalog No. TD-HX959026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG4-lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD269, B-cell maturation protein, BCMA, BCM, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q02223 & P07766
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,BCMA,JNJ-64007957,JNJ-7957,Ab-957,CAS:2119595-80-9
Background Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell lysis. Teclistamab can be used in studies of diseases related to multiple myeloma (MM).
Note For research use only. Not for use in clinical or therapeutic applications.